Ironwood Pharmaceuticals Inc.
IRWD | NASDAQ
$4.58
+$0.17 (+3.85%)
Sep 22, 2026, 2:33 PM ET · Market open
Market Data
Market Cap $725.94M
Enterprise Value $658.68M
Beta 0.21
Average Volume 2.31M
Shares Outstanding (Diluted) 165.45M
Shares Change YoY 2.31%
Institutional Ownership 98.81%
Exchange NASDAQ
ISIN US46333X1081
Price Performance
Price Change 1M 3.3%
Price Change 3M 14.3%
Price Change 6M 38.2%
Price Change YTD 3.3%
Price Change 1Y 206.3%
Price Change 3Y -52.5%
Price Change 5Y -67.2%
1M CAGR (ann.) 2.1%
1Y CAGR (ann.) 202.1%
5Y CAGR (ann.) -18.4%
All-Time CAGR -4.7%
Valuation
PE Ratio 5.73
Forward PE 3.12
PEG Ratio 0.00
Forward PEG 0.73
PS Ratio 1.86
Forward PS 1.50
PB Ratio -4.49
P/FCF Ratio 3.81
P/Adj. FCF Ratio 4.41
P/OCF Ratio 3.94
EV/Sales 1.69
EV/EBIT 2.74
EV/EBITDA 2.73
EV/FCF 3.45
Earnings Yield 17.5%
FCF Yield 26.3%
Adj. FCF Yield 22.7%
Financial Health
Net Cash $67.26M
Total Debt $11.87M
Cash & Short-Term Investments $79.13M
Total Assets $285.13M
Current Ratio 6.06
Quick Ratio 6.06
Debt / Equity Ratio -2.45
Debt / EBITDA 0.05
Debt / FCF 0.06
OCF / Debt 16.07
Interest Coverage 7.23
Altman Z-Score -1.95
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 99.8%
Operating Profit Margin 60.6%
EBITDA Margin 62.0%
Net Profit Margin 33.4%
FCF Margin 49.0%
Adj. FCF Margin 42.3%
SBC / Revenue 5.8%
SBC Impact (per share) -13.7%
Returns
Return on Assets 45.5%
Return on Equity -57.4%
Return on Invested Capital 57.9%
Return on Capital Employed 93.6%
Return on Tangible Assets 45.8%
Historical Growth (CAGR)
Revenue CAGR 3Y -3.0%
Revenue CAGR 5Y -1.2%
Revenue CAGR 10Y 6.2%
EPS CAGR 3Y 144.6%
EPS CAGR 5Y -24.4%
EPS CAGR 10Y 10.1%
FCF CAGR 3Y -10.2%
FCF CAGR 5Y -3.5%
FCF CAGR 10Y 30.5%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 30
EPS Growth Next 3Y -11.2%
Revenue Growth Next 3Y -10.8%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) $0.30
EPS Growth Est (next Q) 25.0%
Revenue Est (next Q) $119.99M
Revenue Growth Est (next Q) -1.7%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value $3.85
Lynch Upside -12.7%
Price Target $6.68
Price Target Upside 51.5%
Cash Flow
Operating Cash Flow $190.68M
Free Cash Flow $190.68M
Adj. Free Cash Flow $164.56M
FCF Per Share $1.12
OCF Per Share $1.12
OCF/S Ratio 47.7%
Income Statement
Revenue $389.32M
Gross Profit $388.4M
Operating Income $236.08M
EBITDA $241.42M
Net Income $129.87M
EPS (Diluted) $0.77
Revenue / Employee $3.89M
Profit / Employee $1.3M
Employees 100
Add to Watchlist
Select watchlists to add or remove IRWD